Neurodevelopmental effects of anti-epileptic drugs

被引:12
作者
Cross, J. Helen [1 ,2 ]
机构
[1] UCL Institute Child Hlth, Great Ormond St Hosp Children, London WC1N 2AP, England
[2] Natl Ctr Young People Epilepsy, Wolfson Ctr, London WCN1 2AP, England
关键词
Anti-epileptic drugs; Childhood; Pregnancy; Brain development; SEVERE MYOCLONIC EPILEPSY; KINGDOM INFANTILE SPASMS; NEURAL-TUBE DEFECTS; KETOGENIC DIET; CONVULSIVE DISORDERS; COGNITIVE FUNCTION; CHILDREN BORN; 1ST YEAR; CONGENITAL-MALFORMATIONS; VALPROATE EMBRYOPATHY;
D O I
10.1016/j.eplepsyres.2009.08.015
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Use of medication with a desired effect on the central nervous system (as with anti-epileptic drugs) in children wilt undoubtedly cause concern about neurodevelopment. Data are emerging to suggest an effect of anticonvulsants on the developing brain of the unborn child when administered to mothers with epilepsy. This obviously requires detailed evaluation, especially when considering the risks of epilepsy itself. In the child with epilepsy, many of the early onset epilepsies are associated with developmental compromise as part of their clinical profile, and therefore determining the relative effects of the underlying cause, seizures and medication can be difficult. Although data are available with regard to some anti-epileptic drugs (AEDs) they remain lacking particularly in the very young with regard to efficacy as well as neurodevelopmental effects of the newer anti-epileptic drugs. Ongoing evaluation is required to ensure the best clinical practice in each individual. (C) 2009 Published by Elsevier B.V.
引用
收藏
页码:1 / 10
页数:10
相关论文
共 85 条
[1]   The longer term outcome of children born to mothers with epilepsy [J].
Adab, N ;
Kini, U ;
Vinten, J ;
Ayres, J ;
Baker, G ;
Clayton-Smith, J ;
Coyle, H ;
Fryer, A ;
Gorry, J ;
Gregg, J ;
Mawer, G ;
Nicolaides, P ;
Pickering, L ;
Tunnicliffe, L ;
Chadwick, DW .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2004, 75 (11) :1575-1583
[2]   Additional educational needs in children born to mothers with epilepsy [J].
Adab, N ;
Jacoby, A ;
Smith, D ;
Chadwick, D .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2001, 70 (01) :15-21
[3]  
ADENKAMP AP, 2000, EPILEPSIA, V41, P1167
[4]   Vigabatrin as initial therapy for infantile spasms: A European retrospective survey [J].
Aicardi, J ;
Hauser, E ;
Steinbock, H ;
Szyper, M ;
Holsteen, V ;
Ostergaard, J ;
Pedersen, SA ;
Taudorf, K ;
BarthezCarpentier, MA ;
BadinandHubert, N ;
Berquin, P ;
Boulloche, J ;
Bourgeois, M ;
Carriere, JP ;
Chabrol, B ;
Chiron, C ;
Claris, O ;
Echenne, B ;
GauthierMorel, D ;
Livet, MO ;
Lopez, N ;
Mancini, J ;
Netter, JC ;
Quillerou, D ;
Richelme, CH ;
Rousselle, C ;
DeStMartin, A ;
DeSwarte, M ;
Auerswald, G ;
Brandl, U ;
Kurlemann, G ;
Siemes, H ;
Spohr, HL ;
Aarts, WFM ;
Begeer, JH ;
Heersma, DJ ;
Laan, LAEM ;
Peters, ACB ;
Cavazzutti, GB ;
Curatolo, P ;
Fois, A ;
Franzoni, E ;
Gobbi, G ;
Incorpora, G ;
Vigevano, F ;
Campistol, J ;
Campos, J ;
Casas, C ;
Herranz, JL ;
Nieto, M .
EPILEPSIA, 1996, 37 (07) :638-642
[5]   Newer antiepileptic drugs and cognitive issues [J].
Aldenkamp, AP ;
De Krom, M ;
Reijs, R .
EPILEPSIA, 2003, 44 :21-29
[6]  
[Anonymous], 1991, Lancet, V338, P131, DOI 10.1016/0140-6736(91)90133-A
[7]   Antiepileptic drug use of women with epilepsy and congenital malformations in offspring [J].
Artama, M ;
Auvinen, A ;
Raudaskoski, T ;
Isojärvi, I ;
Isojärvi, J .
NEUROLOGY, 2005, 64 (11) :1874-1878
[8]  
Battaglia D, 1999, Eur J Paediatr Neurol, V3, P95, DOI 10.1016/S1090-3798(99)90096-X
[9]  
BOOTH D, 2004, COCHRANE DATABASE SY
[10]   Long-term effects of levetiracetam and topiramate in clinical practice: A head-to-head comparison [J].
Bootsma, H. P. R. ;
Ricker, L. ;
Diepman, L. ;
Gehring, J. ;
Hulsman, J. ;
Lambrechts, D. ;
Leenen, L. ;
Majoie, M. ;
Schellekens, A. ;
de Krom, M. ;
Aldenkamp, A. P. .
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2008, 17 (01) :19-26